drugset / Trial / NCT04993339

Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound

NCT04993339 ↗

Phase 3 Completed 26 enrolled University of Miami Arthrex, Inc. · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this study is to determine whether the use of injectable osteoinductive/osteoconductive compounds (OOC) during Anterior Cruciate Ligament (ACL) reconstructive surgery, combined with an accelerated rehabilitation protocol (ARP) provides clinical outcomes superior to those attained via traditional ACL reconstruction and delayed rehabilitation protocols.

Timeline

Start
2016-10-24
Primary completion
2020-02-20
Completion
2020-02-20

Drugs

EvaluationDrugModalityDoseRoute
Subject OOC Unknown — Other

Indications

No indication recorded.